Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Peter van Tintelen

Showing results (181-190 of 232) with videos related to

Pageof 24
Sort By:
Giornale Italiano Di Cardiologia (2006)|October 30, 2023
[2023 ESC Guidelines for the management of cardiomyopathies]Elena Arbelo, Alexandros Protonotarios, Juan R Gimeno, et al.
Plos One|August 31, 2018
No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathyEdgar T Hoorntje, Anna Posafalvi, Petros Syrris, et al.
European Heart Journal|June 11, 2021
Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk predictionTom E Verstraelen, Freyja H M van Lint, Laurens P Bosman, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 28, 2023
The arrhythmogenic cardiomyopathy phenotype associated with PKP2 c.1211dup variantThomas A Bos, Sebastiaan R D Piers, Marja W Wessels, et al.
European Heart Journal|March 20, 2026
Genetic counselling implementation in dilated cardiomyopathyJob A J Verdonschot, Karin Y van Spaendonck-Zwarts, Debby M E I Hellebrekers, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 24, 2023
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onsetLuisa Marsili, Freyja H M van Lint, Francesco Russo, et al.
Circulation. Genomic and Precision Medicine|September 30, 2022
Genetic Evaluation of A Nation-Wide Dutch Pediatric DCM Cohort: The Use of Genetic Testing in Risk StratificationMarijke H van der Meulen, Johanna C Herkert, Susanna L den Boer, et al.
European Heart Journal|January 25, 2015
Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriersAditya Bhonsale, Judith A Groeneweg, Cynthia A James, et al.
European Heart Journal|April 5, 2011
Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategyImke Christiaans, Erwin Birnie, Gouke J Bonsel, et al.
JACC. Heart Failure|August 9, 2025
Identifying Predictors for Heart Failure Outcomes in Phospholamban p.(Arg14del)-Positive IndividualsMyrthe Y C van der Heide, Tom E Verstraelen, Remco de Brouwer, et al.
Pageof 24

Showing results (181-190 of 232) with videos related to

Sort By:
Pageof 24
Giornale Italiano Di Cardiologia (2006)|October 30, 2023
[2023 ESC Guidelines for the management of cardiomyopathies]Elena Arbelo, Alexandros Protonotarios, Juan R Gimeno, et al.
Plos One|August 31, 2018
No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathyEdgar T Hoorntje, Anna Posafalvi, Petros Syrris, et al.
European Heart Journal|June 11, 2021
Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk predictionTom E Verstraelen, Freyja H M van Lint, Laurens P Bosman, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 28, 2023
The arrhythmogenic cardiomyopathy phenotype associated with PKP2 c.1211dup variantThomas A Bos, Sebastiaan R D Piers, Marja W Wessels, et al.
European Heart Journal|March 20, 2026
Genetic counselling implementation in dilated cardiomyopathyJob A J Verdonschot, Karin Y van Spaendonck-Zwarts, Debby M E I Hellebrekers, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 24, 2023
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onsetLuisa Marsili, Freyja H M van Lint, Francesco Russo, et al.
Circulation. Genomic and Precision Medicine|September 30, 2022
Genetic Evaluation of A Nation-Wide Dutch Pediatric DCM Cohort: The Use of Genetic Testing in Risk StratificationMarijke H van der Meulen, Johanna C Herkert, Susanna L den Boer, et al.
European Heart Journal|January 25, 2015
Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriersAditya Bhonsale, Judith A Groeneweg, Cynthia A James, et al.
European Heart Journal|April 5, 2011
Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategyImke Christiaans, Erwin Birnie, Gouke J Bonsel, et al.
JACC. Heart Failure|August 9, 2025
Identifying Predictors for Heart Failure Outcomes in Phospholamban p.(Arg14del)-Positive IndividualsMyrthe Y C van der Heide, Tom E Verstraelen, Remco de Brouwer, et al.
Pageof 24